Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study.

In adjusted analyses of the WPAI, LS mean scores for School Productivity Loss and Daily Activity Impairment were numerically lower in the G551D /IVA group than in the F508del /SOC group, although differences between groups did not reach statistical significance (Table 3 ).

also in 111,027 other papers